Searched for
MOLBIO DIAGNOSTICS IPO
Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...- Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?Molbio Diagnostics aims to secure ₹200 crore to enhance its capital expenditures through a new issuance of shares. In tandem, the firm inte...
- World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor roundMolbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 cr...
- Rs 7,681 crore IPO rush: Shiprocket, Milky Mist among 9 issues to hit the marketIndia’s primary market is set for a busy week, with nine companies aiming to raise a combined Rs 7,681 crore through IPOs across the mainbo...
- Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPOMolbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. T...
- Molbio diagnostics' Rs 940 crore initial public offering opens August 10The initial public offering price range for Molbio Diagnostics has been established, with a target of raising ₹940 crore. Subscription will...
- Molbio Diagnostics IPO to open on August 10, price band set at Rs 768-807Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore public issue...
- Sebi gives approval to five IPO proposalsThe Securities and Exchange Board of India (Sebi) has given the green light for IPOs from Molbio Diagnostics, LEAP India, Foodlink F&B Hold...
- LEAP India, Eldorado Agritech, 3 others get Sebi's nod to float IPOsAs many as five companies, including supply chain asset pooling firm LEAP India and Eldorado Agritech, have secured Sebi's approval to rais...
- Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 monthsIndian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs i...
- Diagnostics company Molbio files DRHP with Sebi for an IPOMolbio Diagnostics, a Goa-based POC diagnostics company, filed its DRHP to raise Rs 200 crore via fresh issue and 1.25 crore shares through...
- Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMTMorgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias...
- Cyient DLM shares list at a healthy premium. Should you hold or sell?"We continue to advise allotted investors to book profits, and if anyone wishes to buy, they should wait and watch for the counter as marke...
- Solid Start! Cyient DLM shares list at 52% premium over IPO priceIntegrated electronic manufacturing services provider Cyient DLM made a strong debut on the stock exchanges, with shares listing at a premi...
- Cyient DLM IPO: Issue subscribed 67.3 times on last dayCyient DLM's IPO was oversubscribed due to strong demand from institutional and retail investors. Retail investors subscribed 49.2 times, n...
- Cyient DLM IPO continues to garner strong interest on Day 2; issue subscribed 7.6 timesCyient DLM's initial public offering (IPO) received a strong response as the overall issue was subscribed 7.6 times. The retail category ha...
- Cyient DLM IPO opens. Should you subscribe to the issue?Cyient DLM has initiated its initial public offering for subscription, with a price band of INR250-265 ($3.36-$3.55) and a proposed market ...
- Cyient DLM IPO: What GMP indicates ahead of subscriptionCyient DLM is set to start its initial public offering on Tuesday, offering shares in the range of Rs 250-265 with a total value of up to R...
- Cyient DLM chip off a known block, needs time to scale upListed IT company Cyient is the promoter of the company. Given the rich valuation, high risk-taking investors may consider the IPO to parti...
- Indian startup sector funding nosedives 80% in Q3, slowdown to continue: reportThe funding in Indian startups nosedived a massive 80 per cent (year-on-year) in the third quarter (July-September period) this year, with ...
Load More
